Market Tracker

05/27 6:03am ET

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.34
Delayed Data
As of May 26
 0.00 / 0.00%
Today’s Change
0.21
Today|||52-Week Range
0.60
-19.11%
Year-to-Date
No recent news for Mast Therapeutics Inc.

Today’s Trading

Previous close0.34
Today’s open0.36
Day’s range0.33 - 0.37
Volume4,179,754
Average volume (3 months)1,647,923
Market cap$65.6M
Dividend yield--
Data as of 05/26/2016

Growth & Valuation

Earnings growth (last year)-8.70%
Earnings growth (this year)+6.40%
Earnings growth (next 5 years)+57.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.33

Competitors

 Today’s
change
Today’s
% change
CERUCerulean Pharma Inc-0.03-1.25%
KURAKura Oncology Inc-0.08-2.66%
RNNRexahn Pharmaceutica...+0.00+0.85%
VCELVericel Corp-0.06-2.08%
Data as of 05/26/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$39.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Brian M. Culley
Chief Financial Officer, CAO &
Senior VP
Brandi L. Roberts
Corporate headquarters
San Diego, California

Forecasts